ERBB2 and breast carcinoma: The potential therapeutic effectof high-affinity probes such as Gd@C-dots-Cys-ZEGFR:1907 against EGFR in thetherapy of non-small cell lung cancer and PFH/AGM-CBA/HSV-TK/liposome (PAHL)-affibody in the therapy of HER2-positive breast cancer is being studied[43, 44]